🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

NeoGenomics, Inc.

NEO Healthcare
$8.95 +$0.05 (0.56%)
Market Cap: $1.17 B
Gurus Holding
5
Popularity Rank
#2084
% of Shares Held
0.48%
Net Activity (Q1 2026)
+$2.31 M

Guru Ownership Trend

Guru Analysis for NeoGenomics, Inc. (NEO)

NeoGenomics, Inc. (NEO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $5.64 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $2.31 M net inflow during the quarter.

Recent activity highlights Mario Gabelli who increased their stake by 525.0%. Conversely, Paul Tudor Jones reduced exposure by 88.6%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$3.34 M
Total Buy Value
New Buys 2
Additions 2
-$1.03 M
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for NeoGenomics, Inc. (NEO)

Major holders include Renaissance Technologies (RenTech) ($1.89 M), Cliff Asness ($1.24 M), Mario Gabelli ($742,000). According to the latest reported data, 5 tracked investment managers collectively hold approximately 630,545 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $2.31 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited NEO. The total reported sell value was $1.03 M.

Yes, 2 managers opened new positions in NEO, and 2 increased their existing holdings. The total reported buy value was $3.34 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 254,172 $1.89 M Q1 2026
0.00% Add 14.4% 167,363 $1.24 M Q1 2026
0.01% Add 525.0% 100,000 $742,000 Q1 2026
0.00% New Buy 91,190 $676,630 Q1 2026
0.00% Reduce -88.6% 17,820 $132,224 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form